The Kimberly and Eric J. Waldman Department of Dermatology is committed to excellence in research and patient care, offering high-level expertise in medical, surgical, and cosmetic dermatological conditions including eczema, alopecia areata, melanoma, cutaneous T-cell lymphoma, chronic itch disorders, psoriasis, vitiligo, and acne. Led by Emma Guttman-Yassky, MD, PhD, our team is conducting groundbreaking studies to develop new treatments with multiple clinical trials giving our patients access to innovative therapies. We have one of the most active teaching programs of any dermatology residency program in the nation. Recently, we were ranked #1 in Research Output on Doximity Residency Navigator.
The Kimberly and Eric J. Waldman Department of Dermatology is committed to excellence in research and patient care, offering high-level expertise in medical, surgical, and cosmetic dermatological conditions including eczema, alopecia areata, melanoma, cutaneous T-cell lymphoma, chronic itch disorders, psoriasis, vitiligo, and acne. Led by Emma Guttman-Yassky, MD, PhD, our team is conducting groundbreaking studies to develop new treatments with multiple clinical trials giving our patients access to new, innovative therapies. We have one of the most active teaching programs of any dermatology residency program in the nation. Recently, we were ranked #1 in Research Output on Doximity Residency Navigator.
The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai is dedicated to delivering superior, comprehensive dermatologic care that exceeds patient expectations, and to advancing the science ...
Artificial intelligence has enormous potential for diagnosing and treating melanoma and other skin cancers. When it comes to diagnosis, dermoscopy, confocal microscopy, optical coherence tomography, pathology, and whole-body imaging are ...
Each year, the doctors and researchers at the Kimberly and Eric J. Waldman Melanoma and Skin Cancer Center at Mount Sinai diagnose and treat thousands of patients with all types of skin cancer, including melanoma. The goal is not just ...
New drugs for alopecia areata have begun to gain FDA approval, including one in 2023. The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine is on a mission to create even more options through Mount ...
Tape strips, a method that was developed primarily for identifying melanomas, have been adopted as a way to study inflammatory skin disease and skin cancers in a noninvasive way.
The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai is applying its vast trove of basic science and clinical expertise to the exciting and rapidly growing field of cosmetic dermatology.
The Dermatology Advisory Board gathers the perspectives of dermatology patients, physicians, and advocates with an interest in pushing the boundaries of research and clinical care and championing innovative treatments in dermatology.
We recruited top faculty talent in 2023, many of whom do innovative science. They will help to expand our efforts in groundbreaking research and contribute to our upward trajectory as a U.S. and world leader.
The Mark Lebwohl Center for Neuroinflammation and Sensation opened in January 2022 and is advancing multidisciplinary research, bringing together skin biology, immunology, and neuroscience.
The research training program in Systems Skin Biology will take a multidisciplinary approach in teaching scientists to holistically understand human physiology, health, and disease.
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab—a novel, patient-tailored monoclonal antibody therapy—showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped.
Brian S. Kim, MD, MTR, presented virtually as a keynote speaker, at the Anesthesiology Branch of Chinese Geriatric Society 2022 Annual Meeting, Tianjin, China. This popular presentation’s total online viewing clicks were more than 400,000 during the meeting.
Brian S. Kim, MD, MTR, received the inaugural Stephen I Katz, MD, PhD, International Lectureship Award and presented "Neuroimmune Regulation of Itch" at the Society for Investigative Dermatology (SID) annual meeting in Portland, Oregon in May 2022.
"Spotlighting Alopecia” with Emma Guttman-Yassky, MD, PhD, featured an in depth discussion with Louis DePalo, MD, from the Health Center at Hudson Yards.
Emma Guttman-Yassky, MD, PhD, discussed “Inflammatory Skin Diseases: The Translational Revolution” outlining her research which proposed a paradigm shift in the pathogenesis of atopic dermatitis.
